Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · IEX Real-Time Price · USD
0.182
-0.018 (-9.05%)
At close: Jun 24, 2022 4:00 PM
0.190
+0.008 (4.396%)
Pre-market:
Jun 27, 2022 8:13 AM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0 | 0 | 0 | 43 | 48.59 | 36.15 | 20.26 | 6.14 |
|
Revenue Growth (YoY)
|
- | - | - | -11.52% | 34.44% | 78.40% | 229.75% | - |
|
Cost of Revenue
|
0 | 0 | 0 | 34.01 | 38.36 | 29.22 | 13.39 | 5.23 |
|
Gross Profit
|
0 | 0 | 0 | 8.98 | 10.24 | 6.93 | 6.87 | 0.91 |
|
Selling, General & Admin
|
20.5 | 5.32 | 2.3 | 10.79 | 18.51 | 9.36 | 5.84 | 0.28 |
|
Research & Development
|
4.79 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Other Operating Expenses
|
39.34 | 0.12 | 0 | 5.34 | 2.62 | 2.95 | 1.82 | 0 |
|
Operating Expenses
|
64.62 | 5.62 | 2.3 | 16.13 | 21.13 | 12.31 | 7.66 | 0.28 |
|
Operating Income
|
-64.62 | -5.62 | -2.3 | -7.15 | -10.9 | -5.38 | -0.79 | 0.63 |
|
Interest Expense / Income
|
0.01 | 0.45 | 0.08 | 0.73 | 0.58 | 0.75 | 0.24 | 0 |
|
Other Expense / Income
|
-8.2 | 0.8 | 0.03 | 2.67 | -0 | 0.4 | -0.09 | -0 |
|
Pretax Income
|
-56.43 | -6.86 | -2.41 | -10.55 | -11.47 | -6.53 | -0.94 | 0.63 |
|
Income Tax
|
-7.45 | 0 | 0 | 6.35 | -2.39 | -3.75 | -0.13 | 0.21 |
|
Net Income
|
-48.98 | -6.86 | -2.41 | -16.9 | -9.07 | -2.78 | -0.81 | 0.41 |
|
Preferred Dividends
|
0 | 0 | 0 | 2.58 | 2.09 | 0 | 0 | 0 |
|
Net Income Common
|
-48.98 | -6.86 | -2.41 | -19.48 | -11.16 | -2.78 | -0.81 | 0.41 |
|
Shares Outstanding (Basic)
|
24 | 6 | 5 | 0 | 0 | 0 | 0 | 0 |
|
Shares Outstanding (Diluted)
|
24 | 6 | 5 | 0 | 0 | 0 | 0 | 0 |
|
Shares Change
|
310.48% | 8.82% | 2122.42% | 58.78% | 14.65% | 17.72% | 16848.40% | - |
|
EPS (Basic)
|
-2.07 | -1.19 | -0.46 | -81.88 | -75.00 | -21.00 | -7.00 | 633.00 |
|
EPS (Diluted)
|
-2.07 | -1.19 | -0.46 | -81.88 | -75.00 | -21.00 | -7.00 | 633.00 |
|
Free Cash Flow Per Share
|
-0.49 | -0.68 | -0.12 | -10.76 | -18.32 | -20.91 | -9.63 | - |
|
Gross Margin
|
- | - | - | 20.89% | 21.07% | 19.17% | 33.91% | 14.83% |
|
Operating Margin
|
- | - | - | -16.62% | -22.42% | -14.88% | -3.92% | 10.22% |
|
Profit Margin
|
- | - | - | -45.31% | -22.97% | -7.69% | -4.02% | 6.75% |
|
Free Cash Flow Margin
|
- | - | - | -5.95% | -5.65% | -7.56% | -5.28% | - |
|
Effective Tax Rate
|
13.21% | 0.00% | 0.00% | -60.18% | 20.86% | 57.41% | 13.63% | 34.00% |
|
EBITDA
|
-55.74 | -6.3 | -2.33 | -6.92 | -7.67 | -4.42 | -0.54 | - |
|
EBITDA Margin
|
- | - | - | -16.08% | -15.79% | -12.22% | -2.65% | - |
|
Depreciation & Amortization
|
0.68 | 0.12 | 0 | 2.9 | 3.22 | 1.36 | 0.17 | - |
|
EBIT
|
-56.42 | -6.42 | -2.33 | -9.82 | -10.89 | -5.78 | -0.7 | 0.63 |
|
EBIT Margin
|
- | - | - | -22.84% | -22.41% | -15.98% | -3.48% | 10.22% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).